1. Home
  2. JXN vs ALKS Comparison

JXN vs ALKS Comparison

Compare JXN & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JXN
  • ALKS
  • Stock Information
  • Founded
  • JXN 1961
  • ALKS 1987
  • Country
  • JXN United States
  • ALKS Ireland
  • Employees
  • JXN N/A
  • ALKS N/A
  • Industry
  • JXN Life Insurance
  • ALKS Biotechnology: Pharmaceutical Preparations
  • Sector
  • JXN Finance
  • ALKS Health Care
  • Exchange
  • JXN Nasdaq
  • ALKS Nasdaq
  • Market Cap
  • JXN 5.6B
  • ALKS 4.8B
  • IPO Year
  • JXN N/A
  • ALKS 1991
  • Fundamental
  • Price
  • JXN $81.85
  • ALKS $30.84
  • Analyst Decision
  • JXN Hold
  • ALKS Buy
  • Analyst Count
  • JXN 5
  • ALKS 13
  • Target Price
  • JXN $94.80
  • ALKS $38.85
  • AVG Volume (30 Days)
  • JXN 637.3K
  • ALKS 1.6M
  • Earning Date
  • JXN 05-07-2025
  • ALKS 07-23-2025
  • Dividend Yield
  • JXN 3.91%
  • ALKS N/A
  • EPS Growth
  • JXN N/A
  • ALKS N/A
  • EPS
  • JXN 1.09
  • ALKS 2.09
  • Revenue
  • JXN $7,422,000,000.00
  • ALKS $1,513,770,000.00
  • Revenue This Year
  • JXN $114.75
  • ALKS N/A
  • Revenue Next Year
  • JXN $2.67
  • ALKS $4.11
  • P/E Ratio
  • JXN $74.89
  • ALKS $14.52
  • Revenue Growth
  • JXN 110.55
  • ALKS N/A
  • 52 Week Low
  • JXN $64.70
  • ALKS $22.90
  • 52 Week High
  • JXN $115.22
  • ALKS $36.45
  • Technical
  • Relative Strength Index (RSI)
  • JXN 49.30
  • ALKS 47.14
  • Support Level
  • JXN $78.76
  • ALKS $29.20
  • Resistance Level
  • JXN $84.30
  • ALKS $30.57
  • Average True Range (ATR)
  • JXN 2.18
  • ALKS 0.70
  • MACD
  • JXN -0.44
  • ALKS -0.10
  • Stochastic Oscillator
  • JXN 27.20
  • ALKS 27.54

About JXN Jackson Financial Inc.

Jackson Financial Inc helps Americans grow and protect their retirement savings and income to enable them to pursue financial freedom for life. Its retail product offerings are comprised of annuities, designed to help retail investors save for and live in retirement. Its diverse suite of annuities includes a variable, fixed index, and fixed annuities. The company manages its business through three segments: Retail Annuities, Institutional Products, and Closed Life and Annuity Blocks and Corporate and Other segments. The company generates the majority of its revenue from the Retail Annuities segment, which offers a variety of retirement income and savings products of variable annuities, registered index-linked annuities ("RILA"), fixed index annuities, fixed annuities, and payout annuities.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: